In 2017, Thomas E. Hughes, Ph.D. earned $745.50K in total compensation at Larimar Therapeutics, including $497.00K salary and $248.50K bonus. Led Larimar Therapeutics as CEO for 9 years.
Compensation History
Annual executive compensation data for Thomas E. Hughes, Ph.D., including salary, bonuses, and stock awards.
Year
2017
Total Compensation
$745.50K
Salary
$497.00K
Bonus
$248.50K
Other
$0.00
Salary
$497.00KBoard Justification
The compensation philosophy focuses on attracting and retaining talented executives through competitive salaries and performance-based bonuses.
Bonus
$248.50KBoard Justification
Performance-based cash bonuses awarded for achieving corporate goals in 2017.
Other Compensation
$0.00Board Justification
No other compensation reported for 2017.
Restricted Stock
Board Justification
No stock vested in 2017 as per the provided information.
Performance Metrics
Performance metrics include achieving corporate goals related to product development and operational milestones.
Thomas E. Hughes, Ph.D.
Ex-CEO of Larimar Therapeutics
Education
Ph.D. in nutritional biochemistry from Tufts University; M.S. in Zoology from Virginia Polytechnic Institute; B.A. in biology from Franklin and Marshall College.
Sector of Economy
Healthcare
Born
January 1, 1960 - 65 years ago
CEO of Larimar Therapeutics for
9 years 0 months (Oct 2008 - Oct 2017)
Previous Experience
Chief Executive Officer of Zafgen, Inc.; various positions at Novartis AG.
Other Larimar Therapeutics CEOs
Holdings
Track Thomas E. Hughes, Ph.D.'s stock holdings and portfolio value over time.
Insider Trading
Thomas E. Hughes, Ph.D.'s recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Thomas E. Hughes, Ph.D. with competitor CEOs and industry peers.